Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alemtuzumab in Renal Transplant Recipients
NCT01213329Phase 4Terminated
- Sponsor
- Northwestern University
- Start
- Feb 2006
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of alemtuzumab in kidney transplantation, sponsored by Northwestern University. Started Feb 2006; status: terminated.
02
Drugs
alemtuzumab
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT01213329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01213329.